Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study)

Background The current prevalence of esophagitis in southern Europe is unknown. In addition, the risk factors for reflux esophagitis are not fully understood. Objective The objective of this article is to assess the prevalence and risk factors for esophagitis in Spain. Methods A prospective, observa...

Descripción completa

Detalles Bibliográficos
Autores: Piqué, N, Ponce, M, Garrigues, V, Rodrigo, L, Calvo, F, de Argila, CM, Borda, F, Naranjo, A, Alcedo, J, Soria, MJ, Rey, E, Bujanda, L, Gisbert, JP, Suarez, D, Calvet, X, Ponce, J
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2016
País:España
Institución:Institut d'Investigació i Innovació Parc Taulí (I3PT)
Repositorio:r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
OAI Identifier:oai:i3pt.fundanetsuite.com:p6057
Acceso en línea:https://i3pt.portalinvestigacion.com/publicaciones/6057
Access Level:acceso abierto
Palabra clave:Endoscopy
severe esophagitis
nonsteroidal anti-inflammatory drugs (NSAID)
gastro-esophageal reflux disease (GERD)
hiatal hernia
questionnaires
gastrointestinal symptoms
Barrett's esophagus
id ES_e21ff1f0cafa69a8fc263c3423e3bbff
oai_identifier_str oai:i3pt.fundanetsuite.com:p6057
network_acronym_str ES
network_name_str España
repository_id_str
spelling Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study)Piqué, NPonce, MGarrigues, VRodrigo, LCalvo, Fde Argila, CMBorda, FNaranjo, AAlcedo, JSoria, MJRey, EBujanda, LGisbert, JPSuarez, DCalvet, XPonce, JEndoscopysevere esophagitisnonsteroidal anti-inflammatory drugs (NSAID)gastro-esophageal reflux disease (GERD)hiatal herniaquestionnairesgastrointestinal symptomsBarrett's esophagusBackground The current prevalence of esophagitis in southern Europe is unknown. In addition, the risk factors for reflux esophagitis are not fully understood. Objective The objective of this article is to assess the prevalence and risk factors for esophagitis in Spain. Methods A prospective, observational, cross-sectional, multicenter study (PRESS study) was conducted among 31 gastrointestinal endoscopy units throughout Spain. A total of 1361 patients undergoing upper gastrointestinal endoscopy were enrolled. Sociodemographic, clinical and treatment data were recorded. Results A total of 95% of patients were Caucasian and 52% were male (mean age: 5317 years). The most frequent symptoms prompting endoscopy were heartburn (40%), regurgitation (26%) and dysphagia (15%). Fifty-four percent of patients undergoing endoscopy were receiving proton pump inhibitor (PPI) treatment. Esophagitis (mainly mild-moderate) was present in 154 (12.4%) patients. The severe form was recorded in only 11 (0.8%) patients. Multivariate analysis results indicated that the likelihood of esophagitis was higher in men (OR=1.91, 95% CI=1.31-2.78), in patients with high GERD-Q scores (OR=1.256, 95% CI=1.176-1.343), weight increase (OR=1.014, 95% CI=1.003-1.025) and high alcohol consumption (OR=2.49, 95% CI=1.16-5.36). Conclusion Severe esophagitis is a rare finding in the Spanish population. Male gender, high GERD-Q score, weight increase and high alcohol consumption are main risk factors for its appearance.WILEY2016info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://i3pt.portalinvestigacion.com/publicaciones/6057United European Gastroenterology JournalISSN: 20506406ISSNe: 20506414reponame:r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulíinstname:Institut d'Investigació i Innovació Parc Taulí (I3PT)Inglésinfo:eu-repo/semantics/openAccessoai:i3pt.fundanetsuite.com:p60572026-06-21T15:30:37Z
dc.title.none.fl_str_mv Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study)
title Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study)
spellingShingle Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study)
Piqué, N
Endoscopy
severe esophagitis
nonsteroidal anti-inflammatory drugs (NSAID)
gastro-esophageal reflux disease (GERD)
hiatal hernia
questionnaires
gastrointestinal symptoms
Barrett's esophagus
title_short Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study)
title_full Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study)
title_fullStr Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study)
title_full_unstemmed Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study)
title_sort Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study)
dc.creator.none.fl_str_mv Piqué, N
Ponce, M
Garrigues, V
Rodrigo, L
Calvo, F
de Argila, CM
Borda, F
Naranjo, A
Alcedo, J
Soria, MJ
Rey, E
Bujanda, L
Gisbert, JP
Suarez, D
Calvet, X
Ponce, J
author Piqué, N
author_facet Piqué, N
Ponce, M
Garrigues, V
Rodrigo, L
Calvo, F
de Argila, CM
Borda, F
Naranjo, A
Alcedo, J
Soria, MJ
Rey, E
Bujanda, L
Gisbert, JP
Suarez, D
Calvet, X
Ponce, J
author_role author
author2 Ponce, M
Garrigues, V
Rodrigo, L
Calvo, F
de Argila, CM
Borda, F
Naranjo, A
Alcedo, J
Soria, MJ
Rey, E
Bujanda, L
Gisbert, JP
Suarez, D
Calvet, X
Ponce, J
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Endoscopy
severe esophagitis
nonsteroidal anti-inflammatory drugs (NSAID)
gastro-esophageal reflux disease (GERD)
hiatal hernia
questionnaires
gastrointestinal symptoms
Barrett's esophagus
topic Endoscopy
severe esophagitis
nonsteroidal anti-inflammatory drugs (NSAID)
gastro-esophageal reflux disease (GERD)
hiatal hernia
questionnaires
gastrointestinal symptoms
Barrett's esophagus
description Background The current prevalence of esophagitis in southern Europe is unknown. In addition, the risk factors for reflux esophagitis are not fully understood. Objective The objective of this article is to assess the prevalence and risk factors for esophagitis in Spain. Methods A prospective, observational, cross-sectional, multicenter study (PRESS study) was conducted among 31 gastrointestinal endoscopy units throughout Spain. A total of 1361 patients undergoing upper gastrointestinal endoscopy were enrolled. Sociodemographic, clinical and treatment data were recorded. Results A total of 95% of patients were Caucasian and 52% were male (mean age: 5317 years). The most frequent symptoms prompting endoscopy were heartburn (40%), regurgitation (26%) and dysphagia (15%). Fifty-four percent of patients undergoing endoscopy were receiving proton pump inhibitor (PPI) treatment. Esophagitis (mainly mild-moderate) was present in 154 (12.4%) patients. The severe form was recorded in only 11 (0.8%) patients. Multivariate analysis results indicated that the likelihood of esophagitis was higher in men (OR=1.91, 95% CI=1.31-2.78), in patients with high GERD-Q scores (OR=1.256, 95% CI=1.176-1.343), weight increase (OR=1.014, 95% CI=1.003-1.025) and high alcohol consumption (OR=2.49, 95% CI=1.16-5.36). Conclusion Severe esophagitis is a rare finding in the Spanish population. Male gender, high GERD-Q score, weight increase and high alcohol consumption are main risk factors for its appearance.
publishDate 2016
dc.date.none.fl_str_mv 2016
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://i3pt.portalinvestigacion.com/publicaciones/6057
url https://i3pt.portalinvestigacion.com/publicaciones/6057
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv WILEY
publisher.none.fl_str_mv WILEY
dc.source.none.fl_str_mv United European Gastroenterology Journal
ISSN: 20506406
ISSNe: 20506414
reponame:r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
instname:Institut d'Investigació i Innovació Parc Taulí (I3PT)
instname_str Institut d'Investigació i Innovació Parc Taulí (I3PT)
reponame_str r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
collection r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869422356802306048
score 15,812429

Similares en LA Referencia